Clearmind Medicine Inc. (NASDAQ:CMND) shares are up Tuesday after the company announced it signed an exclusive patent licensing agreement with Yissum Research Development. What Happened ...

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Prime Medicine wasn’t one of them. The 10 stocks that made the ...

Stock prices may also move more quickly in this environment. Investors who anticipate trading during these times are strongly advised to use limit orders. Real-time Data is provided using Nasdaq ...

Editas Medicine, Inc. (NASDAQ: EDIT) incurred a loss of 82 cents per share in the second quarter of 2024, wider than the Zacks Consensus Estimate of a loss of 69 cents. The company had reported a ...

On the financial front, Disc Medicine announced a public stock offering of approximately $178 million, led by Frazier Life Sciences and Logos Capital, to advance research and clinical development ...

The "middlemen of medicine" have become obstacles to progress, often perpetuating inefficiencies and exacerbating healthcare's existing problems.

Clearmind Medicine filed an international patent for a treatment that aims to enhance addiction treatment safety and efficacy. Clearmind Medicine secures a U.S. patent for its MEAI-based binge ...

The upgrade to Outperform reflects the firm's positive outlook on the stock's potential, based on the detailed financial analysis and the underlying value of Editas Medicine's technology and assets.

Prime Medicine, Inc. (PRME – Research Report ... Analyst Arthur He CFA from H.C. Wainwright maintained a Buy rating on the stock and has a $10.00 price target. Arthur He CFA has given his ...

Barclays dropped their target price on Editas Medicine from $7.00 to $5.00 and set an “equal weight” rating on the stock in a research report on Tuesday. Bank of America raised shares of ...

Clearmind Medicine Inc. (NASDAQ ... According to data from Benzinga Pro, the stock experienced above-average trading volume of 3.60 million shares compared to its average volume of 71,163.